Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.

Molecular changes in the heart of a severe case of arrhythmogenic right ventricular cardiomyopathy caused by a desmoglein-2 null allele.

INTRODUCTION: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic disorder caused by mutations in desmosomal genes. It is often associated with life-threatening arrhythmias. Some affected individuals develop progressive heart failure and may require cardiac transplantation. METHODS:...

Full description

Bibliographic Details
Main Authors:	Gehmlich, K, Syrris, P, Reimann, M, Asimaki, A, Ehler, E, Evans, A, Quarta, G, Pantazis, A, Saffitz, J, McKenna, W
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Novel missense mutations in exon 15 of desmoglein-2: role of the intracellular cadherin segment in arrhythmogenic right ventricular cardiomyopathy?
by: Gehmlich, K, et al.
Published: (2010)

Mechanistic insights into arrhythmogenic right ventricular cardiomyopathy caused by desmocollin-2 mutations.
by: Gehmlich, K, et al.
Published: (2011)

Genetics of and pathogenic mechanisms in arrhythmogenic right ventricular cardiomyopathy
by: Vimalanathan, A, et al.
Published: (2018)

Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria.
by: Quarta, G, et al.
Published: (2011)

Endurance Training Provokes Arrhythmogenic Right Ventricular Cardiomyopathy Phenotype in Heterozygous Desmoglein-2 Mutants: Alleviation by Preload Reduction
by: Fabritz, L, et al.
Published: (2024)

Desmoglein-2 interaction is crucial for cardiomyocyte cohesion and function.
by: Schlipp, A, et al.
Published: (2014)

A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions.
by: Gehmlich, K, et al.
Published: (2011)

Missense mutations in Desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro
by: Beffagna, G, et al.
Published: (2007)

The Majority of Plakophilin-2 Mutations in Arrhythmogenic Cardiomyopathy are Associated with Haploinsufficiency in the Myocardium and Epidermis
by: Rasmussen, T, et al.
Published: (2012)

Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes
by: Matolweni, L, et al.
Published: (2006)

Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy
by: Roberts, JD, et al.
Published: (2019)

Truncating plakophilin-2 mutations in arrhythmogenic cardiomyopathy are associated with protein haploinsufficiency in both myocardium and epidermis.
by: Rasmussen, T, et al.
Published: (2014)

A modelling and imaging approach to further understanding of pathophysiology in arrhythmogenic cardiomyopathy
by: Marinov, P
Published: (2020)

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
by: Petersen, SE, et al.
Published: (2008)

Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes.
by: Proven, A, et al.
Published: (2006)

Generation of mice with a conditional Foxp2 null allele.
by: French, C, et al.
Published: (2007)

Common filaggrin null alleles are not associated with hymenoptera venom allergy in Europeans.
by: Aslam, A, et al.
Published: (2011)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
by: Watkins, H, et al.
Published: (2005)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery.
by: Westaby, S, et al.
Published: (1997)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death?
by: Berman, M, et al.
Published: (2010)

Is stress cardiomyopathy the underlying cause of ventricular dysfunction associated with brain death?
by: Berman, M, et al.
Published: (2010)

Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy.
by: Hoskins, A, et al.
Published: (2010)

The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes
by: Graustein, A, et al.
Published: (2017)

Structural and signaling proteins in the Z-disk and their role in cardiomyopathies
by: Noureddine, M, et al.
Published: (2023)

Mylk3 null C57BL/6N mice develop cardiomyopathy, whereas Nnt null C57BL/6J mice do not
by: Williams, Jack L., et al.
Published: (2020)

Combination of Whole Genome Sequencing, Linkage and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy with Features of Left Ventricular Non-Compaction.
by: Hastings, R, et al.
Published: (2016)

The role of Z-disc proteins in myopathy and cardiomyopathy
by: Wadmore, K, et al.
Published: (2021)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
by: Petersen, SE, et al.
Published: (2009)

Tako-tsubo cardiomyopathy presenting with features of left ventricular non-compaction.
by: Karamitsos, T, et al.
Published: (2008)

FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development
by: Davis, H, et al.
Published: (2011)

FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development.
by: Davis, H, et al.
Published: (2011)

MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy
by: Gehmlich, K, et al.
Published: (2016)

The giant titin: how to evaluate its role in cardiomyopathies
by: Azad, A, et al.
Published: (2019)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk
by: Kyriakou, T, et al.
Published: (2014)

A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk.
by: Kyriakou, T, et al.
Published: (2014)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
by: Ashrafian, H, et al.
Published: (2008)